Search This Blog

Wednesday 19 October 2016

WEB-RADR - innovative use of mobile technology and social media to monitor safety of medicines

The European Medicines Agency is today hosting an update workshop on the 3 year

Innovative Medicines Initiative WEB-RADR project, which was launched in September 2014.
The project includes a series of work packages for partner organisations in Europe and the USA aimed at developing and evaluating use of mobile technology and social media as tools to monitor the safety of medicines.
Patients experiencing suspected adverse reactions to medicines can report these to their physician or pharmacist. In the UK and since 2014 throughout the European Union, patients can now also report suspected drug reactions direct to their national medicine safety authority. However reporting is inconsistent and important adverse side-effects may not be detected until a large number of patients have already been exposed to risk from a medicine.

Three countries in Europe - the UK, the Netherlands and Croatia - are now to evaluating a WEB-RADR mobile app for reporting suspected adverse drug reactions (side effects). The app allows patients and health professionals to reports suspected adverse drug reactions securely to the relevant National Medicines Regulatory Authority.

The Workshop is reporting on experience so far of app-based safety reporting, perspectives and expectations from patients and health professionals and data protection issues.

No comments:

Post a Comment